Investor Lists

Genomics investors in Asia

Updated 7 November 2026

Firms observed backing a genomics company in Asia in the last two years, wherever the firm is based.

See all 61 →The top 25
61investors on the list+11 this week
320cheques in 12 months+20% against the market
$198Mmedian round they joined+2378% against the market median
87%wrote a cheque in 12 months
46%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (24)

  1. 1Tengxun TouziDeploying nowVC firm · China553$50Mmedian roundNov 2026last seen
  2. 2Qiming Venture PartnersDeploying nowVC firm · Hong Kong SAR China526$25Mmedian roundOct 2026last seen
  3. 3Matrix Partners ChinaDeploying nowVC firm · United States295$16Mmedian roundNov 2026last seen
  4. 4Hill House CapitalDeploying nowFamily office · Singapore248$60Mmedian roundSept 2026last seen
  5. 5Vivo CapitalDeploying nowPrivate equity · United States140$64Mmedian roundSept 2026last seen
  6. 6CAS StarDeploying nowVC firm · China116$14Mmedian roundNov 2026last seen
  7. 7Baidu VenturesDeploying nowVC firm · China107$12Mmedian roundJul 2026last seen
  8. 8AlibabaDeploying nowGrowth equity · United States83$150Mmedian roundOct 2026last seen
  9. 9UOB VentureDeploying nowVC firm · Singapore77$8Mmedian roundAug 2026last seen
  10. 10BaiduDeploying nowInvestment firm · China72$36Mmedian roundNov 2026last seen
  11. 11Eastern Bell CapitalDeploying nowPrivate equity · China72$15Mmedian roundJul 2026last seen
  12. 12iGlobe PartnersDeploying nowVC firm · Singapore17$300Mmedian roundJul 2026last seen
  13. 13TAL Education GroupDeploying nowCorporate VC · China15$46Mmedian roundApr 2026last seen
  14. 14Mirae AssetDeploying nowVC firm · United States14$53Mmedian roundSept 2026last seen
  15. 15Ivy CapitalDeploying nowHedge fund · China9$249Mmedian roundJul 2026last seen
  16. 16CPEDeploying nowGrowth equity · China5$2Bmedian roundOct 2026last seen
  17. 17Yali CapitalDeploying nowVC firm · India5$5.3Mmedian roundSept 2026last seen
  18. 18HongShanDeploying nowVC firm5$103Mmedian roundJul 2026last seen
  19. 19Venture capital firmsquietVC firm5$7.2Mmedian roundOct 2025last seen
  20. 20Alibaba CloudDeploying nowCorporate VC · China4$197Mmedian roundJul 2026last seen
  21. 21CITIC SecuritiesDeploying nowInvestment bank · China4$3Bmedian roundOct 2026last seen
  22. 22Lighthouse CapitalDeploying nowGrowth equity · Kenya4$9.1Mmedian roundJul 2026last seen
  23. 23Luminous VenturesDeploying nowVC firm · China4$26Mmedian roundOct 2026last seen
  24. 24Ashish KacholiaDeploying nowAngel · India4$12Mmedian roundOct 2026last seen
  25. 25Pudong Venture CapitalDeploying nowGrowth equity4$459Mmedian roundNov 2026last seen
36 more on this list

All 61 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about genomics investors in Asia

Who are the most active genomics investors in Asia?

By cheques observed, the most active are Tengxun Touzi, Qiming Venture Partners, Matrix Partners China, Hill House Capital and Vivo Capital.

How many genomics investors in Asia are there?

61 are on record. 87% made an investment in the last 12 months and 46% have led a round.

Which stages do genomics investors in Asia back?

Of the rounds with a named stage in the last 12 months, mostly Series B (23%) and Series A (20%).

How big are the rounds genomics investors in Asia join?

The typical (median) round among the leading investors here is $46M.

Which sectors do genomics investors in Asia back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which genomics investors in Asia lead the most rounds?

Tengxun Touzi (20 led), Qiming Venture Partners (8 led) and Baidu (4 led).

Where are genomics investors in Asia based?

Among the most active, most are based in China (11), the United States (4) and Singapore (3).

What have genomics investors in Asia invested in recently?

Recent rounds include aSand.ai (Series A, Nov 2026, with Wangsu Science & Technology), T-Therapeutics (Series B, Nov 2026, with Tengxun Touzi) and Sand.ai (Series A, Nov 2026, with Wangsu Science & Technology).

Built from the rounds we watched, refreshed every night. How we count · Report a correction